HPV vaccine delivery with childhood shots
Treatments studied
Part of Infections clinical trials.
This trial tests a way to give HPV vaccines along with routine childhood immunizations in Ghana. It aims to protect against HPV, a virus that can cause cervical cancer, by making it easier to get the vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy child between 9 months and 5 years old, or an unmarried female between 15 and 20 years old.
- If you’re a child, be up to date on routine childhood vaccines (like polio, measles).
- Live in the study area and plan to stay for the whole study.
- Be HIV-negative (or if you’re a baby, your mom needs to have tested negative during pregnancy).
- If you’re a young female, not be pregnant and use birth control during the study (unless you’re a child where this doesn’t apply).
- Not have had the HPV vaccine before (for the older female group).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how HPV vaccines are given to girls in Ethiopia, aiming to improve access and uptake. It involves interviews and surveys with girls and their caregivers.
This study tests whether a single dose of the HPV vaccine (Gardasil 9) can reduce HPV infection and transmission in women. It might help prevent cervical cancer and other HPV-related conditions.
This trial studies whether giving one dose of the HPV vaccine to boys, in addition to vaccinating girls, helps protect more people from HPV-related cancers. Boys aged 14-18 who live in certain communities in Tanzania may be able to take part.
This study combines HPV vaccination with other health services for young people in Ivory Coast. It aims to protect adolescents against HPV, which can cause cancer, while also checking their overall health and well-being.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
Hear when a new HPV Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.